Revenue GrowthThe moderate improvement in revenue suggests Pascal Biosciences is expanding its market presence and product adoption, which is crucial for long-term growth in the biopharmaceutical sector.

Cash Flow ImprovementPositive free cash flow indicates better cash management and operational efficiency, providing financial flexibility for future investments and growth.

Gross Profit MarginA healthy gross profit margin demonstrates strong pricing power and cost management, essential for sustaining profitability as the company scales.

Bears Say

Profitability ChallengesOngoing profitability challenges highlight the need for cost control and revenue growth to achieve sustainable financial health, impacting long-term viability.

Historical Negative EquityHistorical negative equity suggests past financial struggles, potentially limiting access to capital and affecting investor confidence in the company's stability.

Reliance On FinancingDependence on external financing could strain financial resources and increase risk, especially if market conditions tighten or interest rates rise.

Pascal Biosciences Inc News

Nevis Brands Expands Market Presence and Strengthens Financial Position

The latest announcement is out from Pascal Biosciences Inc ( ($TSE:NEVI) ). Nevis Brands Inc. has announced significant...

2M ago

Nevis Brands Expands Major™ Cannabis Beverage Line in U.S. Markets

Pascal Biosciences Inc ( ($TSE:NEVI) ) has shared an announcement. Nevis Brands Inc. has announced the expansion of...

3M ago

Nevis Brands Reports 16% Revenue Growth in Q3 2025 Amid Market Expansion

An update from Pascal Biosciences Inc ( ($TSE:NEVI) ) is now available. Nevis Brands Inc. reported a 16%...

4M ago

Nevis Brands Inc. Secures Strong Shareholder Support at AGM

The latest update is out from Pascal Biosciences Inc ( ($TSE:NEVI) ). Nevis Brands Inc. announced the successful...

5M ago

Nevis Brands Expands Major™ Cannabis Beverages to New Mexico

An announcement from Pascal Biosciences Inc ( ($TSE:NEVI) ) is now available. Nevis Brands Inc. has announced a...

5M ago

Nevis Brands Expands Midwest Reach with Strategic Distribution Agreement

Pascal Biosciences Inc ( ($TSE:NEVI) ) has shared an announcement. Nevis Brands Inc. has announced a strategic distribution...

7M ago

Nevis Brands Sees Revenue Growth Amid New Product Launches

The latest announcement is out from Pascal Biosciences Inc ( ($TSE:NEVI) ). Nevis Brands Inc. reported a slight...

7M ago

Nevis Brands Expands Cannabis Beverage Offerings in Illinois and the Carolinas

Pascal Biosciences Inc ( ($TSE:NEVI) ) has provided an announcement. Nevis Brands Inc has launched its Major™ 100mg...

9M ago

Nevis Brands Reports 61% Revenue Growth in Q1 2025

An update from Pascal Biosciences Inc ( ($TSE:NEVI) ) is now available. Nevis Brands Inc reported a significant...

10M ago

Nevis Brands Inc Reports Strong Fiscal Year 2024 Results with Market Expansion

Pascal Biosciences Inc ( ($TSE:NEVI) ) has shared an update. Nevis Brands Inc reported a significant increase in...

10M ago

NEVI FAQ

What was Pascal Biosciences Inc’s price range in the past 12 months?

Pascal Biosciences Inc lowest stock price was C$0.04 and its highest was C$0.10 in the past 12 months.

What is Pascal Biosciences Inc’s market cap?

Pascal Biosciences Inc’s market cap is C$1.78M.

When is Pascal Biosciences Inc’s upcoming earnings report date?

Pascal Biosciences Inc’s upcoming earnings report date is Mar 20, 2026 which is in 44 days.

How were Pascal Biosciences Inc’s earnings last quarter?

Pascal Biosciences Inc released its earnings results on Oct 22, 2025. The company reported -C$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.001.

Is Pascal Biosciences Inc overvalued?

According to Wall Street analysts Pascal Biosciences Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Pascal Biosciences Inc pay dividends?

Pascal Biosciences Inc does not currently pay dividends.

What is Pascal Biosciences Inc’s EPS estimate?

Pascal Biosciences Inc’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Pascal Biosciences Inc have?

Pascal Biosciences Inc has 39,662,727 shares outstanding.

What happened to Pascal Biosciences Inc’s price movement after its last earnings report?

Pascal Biosciences Inc reported an EPS of -C$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Pascal Biosciences Inc?

Currently, no hedge funds are holding shares in TSE:NEVI

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Pascal Biosciences Inc

Pascal Biosciences Inc. (NEVI) is a biotechnology company focused on developing innovative therapies for the treatment of cancer and other serious diseases. The company operates primarily in the biopharmaceutical sector, leveraging advanced research and technology to create novel drug candidates. Pascal Biosciences is engaged in the discovery and development of therapies that aim to enhance the immune response to tumors, with a pipeline that includes both biologics and small molecules designed to address unmet medical needs in oncology.